Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71205-858

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71205-858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Cyclobenzaprine Hydrochloride, showing the molecular arrangement including fused benzene rings and the associated functional groups as depicted.*

FDA Label Image

Image (Image 2)

An illustration of a spoon holding a dollop of cream or paste, likely representing a dosage form or application method related to the product.*

FDA Label Image

Image (Image 3)

An instructional line drawing showing a hand holding a small capsule between thumb and forefinger. The capsule is marked with the word "TOP". The image appears to demonstrate how to hold or handle the capsule properly.*

FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

An instructional illustration showing a hand opening a capsule and emptying its contents as small beads or pellets onto a spoon. The image suggests a method of administration or handling for a capsule dosage form.*

FDA Label Image

Image (Image 6)

An instructional illustration showing a woman holding a spoon near her mouth, appearing to take an oral medication. This black-and-white line drawing suggests the administration of a drug in oral form.*

FDA Label Image

Image (Image 7)

An instructional illustration of a person drinking from a glass, likely demonstrating oral administration of medication.*

FDA Label Image

71205-857-30 (Image 8)

Label for Cyclobenzaprine Hydrochloride 15 mg extended-release capsules, containing 30 capsules per bottle. The label shows the drug name, strength, dosage form, and quantity, noting each capsule contains 15 mg of cyclobenzaprine hydrochloride. It includes storage instructions and manufacturer information for Proficient Rx LP and TWi Pharmaceuticals, Taiwan.*

FDA Label Image

71205-858-30 (Image 9)

Label for Cyclobenzaprine Hydrochloride 30 mg extended-release capsules, containing 30 capsules per bottle. The capsules are described as hard gelatin with an orange opaque cap and white opaque body imprinted with T036 in black ink. The label lists Proficient Rx LP as the packager and TWI Pharmaceuticals, Inc. as the manufacturer, with storage instructions at 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.